New York State, City sue Merck over Vioxx

Share this article:

New York State Attorney General Andrew Cuomo and New York City Mayor Michael Bloomberg have filed a joint lawsuit against Merck, alleging the drugmaker misrepresented the cardiovascular risks associated with its Vioxx painkiller.

The civil lawsuit, filed in New York State Supreme Court, seeks damages, penalties and restitution for taxpayer dollars wrongfully spent on Vioxx prescriptions. It is first case to be brought under New York State's recently enacted False Claims Act.

According to the New York Attorney General's Office, between 1999, when Vioxx was introduced, and 2004 when it was pulled from the market, Medicaid and EPIC spent over $100 million on Vioxx prescriptions in New York State. For its residents receiving Medicaid assistance, New York City paid a substantial share of those costs.

Merck said in a statement that it has not yet received the complaint filed by New York State and New York City seeking Medicaid reimbursement costs.

Merck said it intends to defend against the suit as it has defended against the Medicaid-related suits filed more than a year ago by a handful of other states including Alaska, Louisiana, Mississippi, Montana, Texas and Utah.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.